News_Details

PHEXCOM

Solution BY Communication

>>Back

Regeneron stock falls on new AMD treatment study

Publisher：
Publication：2012/6/15

Regeneron ($REGN), which makes the new wet AMD treatment Eylea, saw its stock falter after a small drugmaker unveiled data from a study testing its AMD treatment in combination with Eylea rival Lucentis.

Excipients

oleaginous vehicle
flavoring agent
viscosity-increasing agent
suspending agent
disintegrant
thickener
solvent
alkalizing agent
chelating agent
emulsifying agent
buffer
adhesive
coating agent
sweetening agent
film-former
gelling agent
solublizing agent
diluent
preservative
carrier